Apollo Hospitals Q1 Results: Net profit jumps 38% YoY to Rs 610 crore; revenue rises 21%

Apollo Hospitals Enterprise on Wednesday, August 12, reported a 38.4% year-on-year (YoY) jump in consolidated net profit to Rs 610 crore for the quarter ended June 30, 2026 (Q1FY27), compared with Rs 441 crore reported in the corresponding quarter of the previous financial year.

Revenue from operations rose 20.6% YoY to Rs 7,044 crore in Q1FY27, compared with Rs 5,842 crore in the year-ago period, according to the company’s exchange filing.

The healthcare major’s earnings before interest, taxes, depreciation and amortisation (EBITDA) increased 28.2% YoY to Rs 1,092 crore from Rs 852 crore in Q1FY26. The EBITDA margin also improved to 15.5% from 14.6% a year earlier.

Ahead of the results, Apollo Hospitals shares settled 1.72% lower at Rs 8,597 apiece on the NSE on Wednesday.

ALSO READ: Tata Sons’ IPO can take a page from a Hong Kong titan

Key Operational Highlights

Apollo Hospitals said revenue from its Healthcare Services business grew 22% year-on-year during the quarter, while EBITDA stood at Rs 862 crore.Apollo Health and Lifestyle reported a 15% YoY increase in revenue to Rs 499 crore.

Apollo HealthCo reported revenue of Rs 2,977 crore, while EBITDA stood at Rs 171 crore.

The company said revenue growth was driven by higher volumes in its specialties and an increase in high-complexity clinical work.

Capacity Expansion

Apollo Hospitals continued its capacity expansion during the quarter with the launch of a 180-bed hospital in Sarjapur, Bengaluru. The company’s Gurugram facility remains on track for commissioning in Q3FY27.

The company also announced plans to expand its existing hospital facilities in Indore and Guwahati by 148 beds. In addition, Apollo plans to add four new hospitals in Indore, Dwarka, Delhi Proton Centre and Ranchi, with a combined capacity of around 1,200 beds.

With these additions, Apollo Hospitals plans to add more than 5,000 beds, including 4,700 census beds, over the next five years.

International Patient Business

Apollo’s International Patient Services division continued to gain traction, with revenue rising 26% year-on-year during the quarter. The company said the growth reinforces its position as a preferred healthcare destination for international patients.

Management Commentary

Prathap C. Reddy, Founder and Chairman of Apollo Hospitals Group, said Q1FY27 marked a strong start to the financial year, building on the momentum seen in FY26.

“”Ql FY27 marks a strong start to the year, building on the momentum of FY26. Consolidated revenue grew 21% yearon-year to :f7,043 crore, supported by strong-based performance across Healthcare Services, Diagnostics and Retail

Health, and Digital Health and Pharmacy. The performance reflects the strength of our integrated model and the

continued trust that patients and their families place in Apollo,” said Reddy.

Apollo HealthCo Transaction

Apollo Hospitals also informed the exchanges that it has taken note of a proposed transfer by Apollo HealthCo Ltd, a material subsidiary, of its undertaking relating to the procurement and wholesale distribution of fast-moving consumer goods, wellness and personal care products, including over-the-counter and non-prescription consumer healthcare products.

The business is proposed to be transferred as a going concern on a slump-sale basis to Apollo Consumer Products Ltd, a wholly owned subsidiary of Apollo HealthCo, subject to shareholder approval.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)